UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G A/1

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO.1)

Oncovista Innovative Therapies, Inc.
_____________________________________________
(Name of Issuer)


Common Shares
__________________________
(Title of Class of Securities)

 68232J105
_________________________
(CUSIP Number)


December 31, 2013
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
£
Rule 13d-1(b)
þ
Rule 13d-1(c)
£
Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


     

 
 
 


CUSIP NO.  68232J105
 
13G A/1
 
1
NAME OF REPORTING PERSON
 
Wexford Spectrum Trading Limited
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)   o
(b)   o
3
SEC USE ONLY
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Cayman Islands
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5
SOLE VOTING POWER
 
0
6
SHARED VOTING POWER
 
1,714,284
7
SOLE DISPOSITIVE POWER
 
0
8
SHARED DISPOSITIVE POWER
 
1,714,284
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,714,284
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAINSHARES
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
 
7.93%
12
TYPE OF REPORTING PERSON
 
CO


     

 
 
 


CUSIP NO.  68232J105
 
13G A/1
 
1
NAME OF REPORTING PERSON
 
Wexford Capital LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)   o
(b)   o
3
SEC USE ONLY
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5
SOLE VOTING POWER
 
0
6
SHARED VOTING POWER
 
1,714,284
7
SOLE DISPOSITIVE POWER
 
0
8
SHARED DISPOSITIVE POWER
 
1,714,284
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,714,284
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAINSHARES
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
 
7.93%
12
TYPE OF REPORTING PERSON
 
PN



     

 
 
 


CUSIP NO. 68232J105
 
13G A/1
 
1
NAME OF REPORTING PERSON
 
Wexford GP LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)   o
(b)   o
3
SEC USE ONLY
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5
SOLE VOTING POWER
 
0
6
SHARED VOTING POWER
 
1,714,284
7
SOLE DISPOSITIVE POWER
 
0
8
SHARED DISPOSITIVE POWER
 
1,714,284
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,714,284
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAINSHARES
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
 
7.93%
12
TYPE OF REPORTING PERSON
 
OO


     

 
 
 


CUSIP NO. 68232J105
 
13G A/1
 
1
NAME OF REPORTING PERSON
 
Charles E. Davidson
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)   o
(b)   o
3
SEC USE ONLY
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5
SOLE VOTING POWER
 
0
6
SHARED VOTING POWER
 
1,714,284
7
SOLE DISPOSITIVE POWER
 
0
8
SHARED DISPOSITIVE POWER
 
1,714,284
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,714,284
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAINSHARES
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
 
7.93%
12
TYPE OF REPORTING PERSON
 
IN


     

 
 
 


CUSIP NO 68232J105
 
13G A/1
 
1
NAME OF REPORTING PERSON
 
Joseph M. Jacobs
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)   o
(b)   o
3
SEC USE ONLY
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5
SOLE VOTING POWER
 
0
6
SHARED VOTING POWER
 
1,714,284
7
SOLE DISPOSITIVE POWER
 
0
8
SHARED DISPOSITIVE POWER
 
1,714,284
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,714,284
 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAINSHARES
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
 
7.93%
12
TYPE OF REPORTING PERSON
 
IN


     

 
 
 

This Amendment No. 1 (this “ Amendment ”) modifies and supplements the 13G initially filed on November 21, 2007 (the “ Statement ”), with respect to the common stock, $0.001 par value per share (the “ Common Stock ”), of OncoVista Innovative Therapies, Inc.., a Nevada corporation (the “ Company ”). Except to the extent supplemented by the information contained in this Amendment No. 1, the Statement, as amended as provided herein, remains in full force and effect. Capitalized terms used herein without definition have the respective meanings ascribed to them in the Statement.

 
Item   1. should be deleted in its entirety and replaced with the following:

Item 1.


 
(a)
Name of Issuer:

OncoVista Innovative Therapies, Inc.
 
 
(b)
Address of Issuer’s Principal Executive Offices:
   

 
 14785 Omicron Drive, Suite 104
 
 San Antonio, TX  78245


Item 2 .   should be deleted in its entirety and replaced with the follow ing:

Item 2.

 
(a)
Name of Persons Filing (collectively, the “ Reporting Persons ”):

(i)  
Wexford Spectrum Trading Limited
(ii)  
Wexford Capital LP
(iii)  
Wexford GP LLC
(iv)  
Charles E. Davidson
(v)  
Joseph M. Jacobs

 
(b)
Address of Principal Business Office, or, if none, Residence of Reporting Persons:

411 West Putnam Avenue, Suite 125
Greenwich, Connecticut 06830

 
(c)
Citizenship:

(i)  
Wexford Spectrum Trading Limited – Cayman Islands
(ii)  
Wexford Capital LP – Delaware
(iii)  
Wexford GP LLC  - Delaware
(iv)  
Charles E. Davidson - United States
(v)  
Joseph M. Jacobs – United States

 
(d)
Title of Class of Securities:

Common Stock, $.001 par value

 
(e)
CUSIP Number:

 
68232J105

 
Item 4 should be deleted in its entirety and replaced with the following:

 
    Item 4     Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. [Information set forth below is on the basis of 21,627,868 shares of common stock issued and outstanding as of November 14, 2013, as reported in the Company’s Form 10Q filed with the Securities and Exchange Commission on November 14, 2013.]

 
(i) Wexford Spectrum Trading Limited
 
(a)
Amount beneficially owned: 1,714,284
 
(b)
Percent of class: 7.93%
 
(c)
Number of shares to which the person has:
 
(i)
Sole power to vote or to direct the vote: 0
 
(ii)
Shared power to vote or to direct the vote: 1,714,284
 
(iii)
Sole power to dispose or to direct the disposition of: 0
 
(iv)
Shared power to dispose or to direct the disposition of: 1,714,284

 
(ii) Wexford Capital LP
 
(a)
Amount beneficially owned: 1,714,284
 
(b)
Percent of class: 7.93%
 
(c)
Number of shares to which the person has:
 
(i)
Sole power to vote or to direct the vote: 0
 
(ii)
Shared power to vote or to direct the vote: 1,714,284
 
(iii)
Sole power to dispose or to direct the disposition of: 0
 
(iv)
Shared power to dispose or to direct the disposition of: 1,714,284

 
(iii) Wexford GP LLC
 
(a)
Amount beneficially owned: 1,714,284
 
(b)
Percent of class: 7.93%
 
(c)
Number of shares to which the person has:
 
(i)
Sole power to vote or to direct the vote: 0
 
(ii)
Shared power to vote or to direct the vote: 1,714,284
 
(iii)
Sole power to dispose or to direct the disposition of: 0
 
(iv)  
    Shared power to dispose or to direct the disposition of: 1,714,284

 
(iv) Charles E. Davidson
 
(a)
Amount beneficially owned: 1,714,284
 
(b)
Percent of class: 7.93%
 
(c)
Number of shares to which the person has:
 
(i)
Sole power to vote or to direct the vote: 0
 
(ii)
Shared power to vote or to direct the vote: 1,714,284
 
(iii)
Sole power to dispose or to direct the disposition of: 0
 
(iv)
Shared power to dispose or to direct the disposition of: 1,714,284

 
(v) Joseph M. Jacobs
 
(a)
Amount beneficially owned: 1,714,284
 
(b)
Percent of class: 7.93%
 
(c)
Number of shares to which the person has:
 
(i)
Sole power to vote or to direct the vote: 0
 
(ii)
Shared power to vote or to direct the vote: 1,714,284
 
(iii)
Sole power to dispose or to direct the disposition of: 0
 
(iv)
Shared power to dispose or to direct the disposition of: 1,714,284

The total shares of Common Stock reported as beneficially owned by each of Wexford Capital LP (“ Wexford Capital ”), Wexford GP LLC (“ Wexford GP ”), Charles E. Davidson (“ Davidson ”) and  Joseph M. Jacobs (“ Jacobs ”) include the shares of Common Stock reported as beneficially owned by  Wexford Spectrum Trading Limited (“WST). Wexford Capital LP may, by reason of its status as investment manager of WST , be deemed to own beneficially the securities of which WST possesses beneficial ownership. Wexford GP may, as the General Partner of Wexford Capital, be deemed to own beneficially the securities of which WST possesses beneficial ownership. Each of Davidson and Jacobs may, by reason of his status as a controlling person of Wexford GP, be deemed to own beneficially the securities of which WST possesses beneficial ownership. Each of Wexford Capital, Wexford GP, Davidson and Jacobs shares the power to vote and to dispose of the securities beneficially owned by WST.  Each of Wexford Capital, Wexford GP, Davidson and Jacobs disclaims beneficial ownership of the securities owned by WSI and this report shall not be deemed as an admission that they are the beneficial owners of such securities except, in the case of Davidson and Jacobs, to the extent of their respective interests in each member of WST.




     

 
 
 


SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 Date: February 14, 2014
Company Name
 
 
WEXFORD SPECTRUM TRADING LIMITED
 
       
 
By:
/s/ Arthur H. Amron
 
 
Name:  
Arthur H. Amron
 
 
Title: 
Vice President and Assistant Secretary
 
       
       
 
WEXFORD CAPITAL LP
 
 
By:
Wexford GP LLC, its General Partner
 
       
 
By:
/s/ Arthur H. Amron
 
 
Name:  
Arthur H. Amron
 
 
Title: 
 Vice President and Assistant Secretary
 
       
 
WEXFORD GP LLC
 
       
 
By:
/s/ Arthur H. Amron
 
 
Name:  
Arthur H. Amron
 
 
Title: 
Vice President and Assistant Secretary
 
       
     
       
 
/s/ Joseph M. Jacobs
 
 
 JOSEPH M. JACOBS
 
       
       
     
       
 
/s/ Charles E. Davidson
 
 
 CHARLES E. DAVIDSON
 
       
       
       
OncoVista Innovative The... (CE) (USOTC:OVIT)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more OncoVista Innovative The... (CE) Charts.
OncoVista Innovative The... (CE) (USOTC:OVIT)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more OncoVista Innovative The... (CE) Charts.